• GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

  • Oct 28 2024
  • Length: 23 mins
  • Podcast

GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

Listen for free

View show details

  • Summary

  • We finally have two FDA-approved treatments for geographic atrophy (GA)—and yet, many retina specialists have been reluctant to embrace them. Join moderator John Kitchens, MD, as he explores this question with Miguel Busquets, MD, and Esther Kim, MD. Further in the episode, they gameplan patient conversations centered around choosing a treatment, ask how heavily to weigh safety when selecting a complement inhibitor, and preview the GA pipeline.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about GA Options in Clinical Therapy: Why Aren't Doctors Embracing Complement Inhibition?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available